ReP USP - Resultado da busca

Artigo de periodico
Detection and quantification of prostaglandin E2 in saliva by liquid chromatography-tandem mass spectrometry using microextraction by packed sorbent (2022)
Oliveira, Gabriela de Moraes ; Dionisio, Thiago José ; Weckwerth, Giovana Maria ; Siqueira-Sandrin, Viviane da Silva ; Polanco, Nelson Leonel Del Hierro ; Faria, Flavio Augusto Cardoso de ; Santos, Carlos Ferreira dos ; Calvo, Adriana Maria
Source: Prostaglandins & Other Lipid Mediators. Unidade: FOB
Subjects: PROSTAGLANDINAS, SALIVA, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Gabriela de Moraes et al. Detection and quantification of prostaglandin E2 in saliva by liquid chromatography-tandem mass spectrometry using microextraction by packed sorbent. Prostaglandins & Other Lipid Mediators, v. 163, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.prostaglandins.2022.106672. Acesso em: 14 nov. 2024.
APA
Oliveira, G. de M., Dionisio, T. J., Weckwerth, G. M., Siqueira-Sandrin, V. da S., Polanco, N. L. D. H., Faria, F. A. C. de, et al. (2022). Detection and quantification of prostaglandin E2 in saliva by liquid chromatography-tandem mass spectrometry using microextraction by packed sorbent. Prostaglandins & Other Lipid Mediators, 163. doi:10.1016/j.prostaglandins.2022.106672
NLM
Oliveira G de M, Dionisio TJ, Weckwerth GM, Siqueira-Sandrin V da S, Polanco NLDH, Faria FAC de, Santos CF dos, Calvo AM. Detection and quantification of prostaglandin E2 in saliva by liquid chromatography-tandem mass spectrometry using microextraction by packed sorbent [Internet]. Prostaglandins & Other Lipid Mediators. 2022 ; 163[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.prostaglandins.2022.106672
Vancouver
Oliveira G de M, Dionisio TJ, Weckwerth GM, Siqueira-Sandrin V da S, Polanco NLDH, Faria FAC de, Santos CF dos, Calvo AM. Detection and quantification of prostaglandin E2 in saliva by liquid chromatography-tandem mass spectrometry using microextraction by packed sorbent [Internet]. Prostaglandins & Other Lipid Mediators. 2022 ; 163[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.prostaglandins.2022.106672
Artigo de periodico
Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway (2020)
Herrera, Naiara A.; Duchatsch, Francine; Tardelli, Lidieli P.; Dionisio, Thiago José ; Santos, Carlos Ferreira dos ; Amaral, Sandra Lia do
Source: Journal of Cardiovascular Pharmacology. Unidade: FOB
Subjects: ANTI-INFLAMATÓRIOS, HORMÔNIOS GLICOCORTICOIDES, PRESSÃO SANGUÍNEA, MIOCÁRDIO, MICRORNAS, EXERCÍCIO FÍSICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERRERA, Naiara A. et al. Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway. Journal of Cardiovascular Pharmacology, v. 76, n. 6, p. 708-714, 2020Tradução . . Disponível em: https://doi.org/10.1097/FJC.0000000000000924. Acesso em: 14 nov. 2024.
APA
Herrera, N. A., Duchatsch, F., Tardelli, L. P., Dionisio, T. J., Santos, C. F. dos, & Amaral, S. L. do. (2020). Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway. Journal of Cardiovascular Pharmacology, 76( 6), 708-714. doi:10.1097/FJC.0000000000000924
NLM
Herrera NA, Duchatsch F, Tardelli LP, Dionisio TJ, Santos CF dos, Amaral SL do. Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway [Internet]. Journal of Cardiovascular Pharmacology. 2020 ; 76( 6): 708-714.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1097/FJC.0000000000000924
Vancouver
Herrera NA, Duchatsch F, Tardelli LP, Dionisio TJ, Santos CF dos, Amaral SL do. Dexamethasone does not inhibit treadmill training–induced angiogenesis in myocardium: role of MicroRNA-126 pathway [Internet]. Journal of Cardiovascular Pharmacology. 2020 ; 76( 6): 708-714.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1097/FJC.0000000000000924
Trabalho de evento-resumo
CYP3A4 polymorphisms correlated with clinical efficacy of ibuprofen after surgery (2020)
Calvo, Adriana Maria ; Santos, Carlos Ferreira dos ; Weckwerth, Giovana Maria ; Oliveira, Gabriela; Dionisio, Thiago José ; Bolani, Bruna ; Ferrari, Lohayne; Alves, Nubia; Moore, Troy; Faria, Flavio Augusto Cardoso de
Conference titles: IADR/AADR/CADR General Session. Unidade: FOB
Subjects: POLIMORFISMO, FARMACOGENÉTICA, CIRURGIA BUCAL, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALVO, Adriana Maria et al. CYP3A4 polymorphisms correlated with clinical efficacy of ibuprofen after surgery. 2020, Anais.. Alexandria: IADR, 2020. Disponível em: https://iadr.abstractarchives.com/abstract/20iags-3322860/cyp3a4-polymorphisms-correlated-with-clinical-efficacy-of-ibuprofen-after-surgery. Acesso em: 14 nov. 2024.
APA
Calvo, A. M., Santos, C. F. dos, Weckwerth, G. M., Oliveira, G., Dionisio, T. J., Bolani, B., et al. (2020). CYP3A4 polymorphisms correlated with clinical efficacy of ibuprofen after surgery. In . Alexandria: IADR. Recuperado de https://iadr.abstractarchives.com/abstract/20iags-3322860/cyp3a4-polymorphisms-correlated-with-clinical-efficacy-of-ibuprofen-after-surgery
NLM
Calvo AM, Santos CF dos, Weckwerth GM, Oliveira G, Dionisio TJ, Bolani B, Ferrari L, Alves N, Moore T, Faria FAC de. CYP3A4 polymorphisms correlated with clinical efficacy of ibuprofen after surgery [Internet]. 2020 ;[citado 2024 nov. 14 ] Available from: https://iadr.abstractarchives.com/abstract/20iags-3322860/cyp3a4-polymorphisms-correlated-with-clinical-efficacy-of-ibuprofen-after-surgery
Vancouver
Calvo AM, Santos CF dos, Weckwerth GM, Oliveira G, Dionisio TJ, Bolani B, Ferrari L, Alves N, Moore T, Faria FAC de. CYP3A4 polymorphisms correlated with clinical efficacy of ibuprofen after surgery [Internet]. 2020 ;[citado 2024 nov. 14 ] Available from: https://iadr.abstractarchives.com/abstract/20iags-3322860/cyp3a4-polymorphisms-correlated-with-clinical-efficacy-of-ibuprofen-after-surgery
Artigo de periodico
AT1 receptor antagonism promotes bone loss attenuation in experimental periodontitis, blocks inflammatory mediators, and upregulates antioxidant enzymes and bone formation markers (2020)
Dionisio, Thiago José ; Souza, Gabriela P.; Colombini-Ishikiriama, Bella Luna ; Garbieri, Thais Francini ; Parisi, Viviane Aparecida ; Oliveira, Gabriela de Moraes ; Cano, Isadora Prado ; Rodini, Camila de Oliveira ; Oliveira, Sandra Helena Penha de ; Greene, Andrew Seth; Santos, Carlos Ferreira dos
Source: Journal of Periodontology. Unidade: FOB
Subjects: RECEPTORES DE ANGIOTENSINA, PERIODONTITE, RATOS, EXPRESSÃO GÊNICA, ANTI-INFLAMATÓRIOS, CITOCINAS, TECIDO CONJUNTIVO, OSSO E OSSOS, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIONISIO, Thiago José et al. AT1 receptor antagonism promotes bone loss attenuation in experimental periodontitis, blocks inflammatory mediators, and upregulates antioxidant enzymes and bone formation markers. Journal of Periodontology, v. 91, n. 4, p. 533-544, 2020Tradução . . Disponível em: https://doi.org/10.1002/JPER.19-0064. Acesso em: 14 nov. 2024.
APA
Dionisio, T. J., Souza, G. P., Colombini-Ishikiriama, B. L., Garbieri, T. F., Parisi, V. A., Oliveira, G. de M., et al. (2020). AT1 receptor antagonism promotes bone loss attenuation in experimental periodontitis, blocks inflammatory mediators, and upregulates antioxidant enzymes and bone formation markers. Journal of Periodontology, 91( 4), 533-544. doi:10.1002/JPER.19-0064
NLM
Dionisio TJ, Souza GP, Colombini-Ishikiriama BL, Garbieri TF, Parisi VA, Oliveira G de M, Cano IP, Rodini C de O, Oliveira SHP de, Greene AS, Santos CF dos. AT1 receptor antagonism promotes bone loss attenuation in experimental periodontitis, blocks inflammatory mediators, and upregulates antioxidant enzymes and bone formation markers [Internet]. Journal of Periodontology. 2020 ; 91( 4): 533-544.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/JPER.19-0064
Vancouver
Dionisio TJ, Souza GP, Colombini-Ishikiriama BL, Garbieri TF, Parisi VA, Oliveira G de M, Cano IP, Rodini C de O, Oliveira SHP de, Greene AS, Santos CF dos. AT1 receptor antagonism promotes bone loss attenuation in experimental periodontitis, blocks inflammatory mediators, and upregulates antioxidant enzymes and bone formation markers [Internet]. Journal of Periodontology. 2020 ; 91( 4): 533-544.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1002/JPER.19-0064
Artigo de periodico
Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9 (2017)
Calvo, Adriana Maria ; Zupelari-Gonçalves, Paulo ; Dionisio, Thiago José ; Brozoski, Daniel Thomas; Faria, Flavio Augusto Cardoso de ; Santos, Carlos Ferreira dos
Source: Journal of Pain Research. Unidade: FOB
Subjects: ANTI-INFLAMATÓRIOS, FARMACOGENÉTICA, MOLAR, DOR, COMPLICAÇÕES PÓS-OPERATÓRIAS, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALVO, Adriana Maria et al. Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9. Journal of Pain Research, v. 10, p. 1581-1589, 2017Tradução . . Disponível em: https://doi.org/10.2147/JPR.S138147. Acesso em: 14 nov. 2024.
APA
Calvo, A. M., Zupelari-Gonçalves, P., Dionisio, T. J., Brozoski, D. T., Faria, F. A. C. de, & Santos, C. F. dos. (2017). Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9. Journal of Pain Research, 10, 1581-1589. doi:10.2147/JPR.S138147
NLM
Calvo AM, Zupelari-Gonçalves P, Dionisio TJ, Brozoski DT, Faria FAC de, Santos CF dos. Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9 [Internet]. Journal of Pain Research. 2017 ; 10 1581-1589.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2147/JPR.S138147
Vancouver
Calvo AM, Zupelari-Gonçalves P, Dionisio TJ, Brozoski DT, Faria FAC de, Santos CF dos. Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9 [Internet]. Journal of Pain Research. 2017 ; 10 1581-1589.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2147/JPR.S138147
Trabalho de evento-resumo periodico
Opposite effects of exercise and dexamethasone on skeletal muscle glucose uptake: role of AMPK and CaMKII (2010)
Amaral, Sandra Lia; Louzada, Juliana Cavalcante de Andrade; Dionísio, Thiago José; Viscelli, Bruno Alvares; Dionísio, Evandro José; Bosqueiro, José Roberto; Martuscelli, Aline Mio
Source: FASEB Journal. Conference titles: Experimental Biology. Unidade: FOB
Subjects: EXERCÍCIO FÍSICO (EFEITOS ADVERSOS), ANTI-INFLAMATÓRIOS, INSULINA, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Sandra Lia et al. Opposite effects of exercise and dexamethasone on skeletal muscle glucose uptake: role of AMPK and CaMKII. FASEB Journal. Washington: Faculdade de Odontologia de Bauru, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2010
APA
Amaral, S. L., Louzada, J. C. de A., Dionísio, T. J., Viscelli, B. A., Dionísio, E. J., Bosqueiro, J. R., & Martuscelli, A. M. (2010). Opposite effects of exercise and dexamethasone on skeletal muscle glucose uptake: role of AMPK and CaMKII. FASEB Journal. Washington: Faculdade de Odontologia de Bauru, Universidade de São Paulo.
NLM
Amaral SL, Louzada JC de A, Dionísio TJ, Viscelli BA, Dionísio EJ, Bosqueiro JR, Martuscelli AM. Opposite effects of exercise and dexamethasone on skeletal muscle glucose uptake: role of AMPK and CaMKII. FASEB Journal. 2010 ; 24[citado 2024 nov. 14 ]
Vancouver
Amaral SL, Louzada JC de A, Dionísio TJ, Viscelli BA, Dionísio EJ, Bosqueiro JR, Martuscelli AM. Opposite effects of exercise and dexamethasone on skeletal muscle glucose uptake: role of AMPK and CaMKII. FASEB Journal. 2010 ; 24[citado 2024 nov. 14 ]
Trabalho de evento-resumo periodico
Dexamethasone negative side effects on insulin signaling is prevented by exercise training: role of IRS-1 and p-AKT (2010)
Dionísio, Thiago José; Louzada, Juliana Cavalcante de Andrade; Viscelli, Bruno Alvares; Dionísio, Evandro José; Martuscelli, Aline Mio; Boaqueiro, José Roberto; Santos, Carlos Ferreira; Amaral, Sandra Lia
Source: FASEB Journal. Conference titles: Experimental Biology. Unidade: FOB
Subjects: EXERCÍCIO FÍSICO, ANTI-INFLAMATÓRIOS, INSULINA, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIONÍSIO, Thiago José et al. Dexamethasone negative side effects on insulin signaling is prevented by exercise training: role of IRS-1 and p-AKT. FASEB Journal. Washington: Faculdade de Odontologia de Bauru, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2010
APA
Dionísio, T. J., Louzada, J. C. de A., Viscelli, B. A., Dionísio, E. J., Martuscelli, A. M., Boaqueiro, J. R., et al. (2010). Dexamethasone negative side effects on insulin signaling is prevented by exercise training: role of IRS-1 and p-AKT. FASEB Journal. Washington: Faculdade de Odontologia de Bauru, Universidade de São Paulo.
NLM
Dionísio TJ, Louzada JC de A, Viscelli BA, Dionísio EJ, Martuscelli AM, Boaqueiro JR, Santos CF, Amaral SL. Dexamethasone negative side effects on insulin signaling is prevented by exercise training: role of IRS-1 and p-AKT. FASEB Journal. 2010 ; 24[citado 2024 nov. 14 ]
Vancouver
Dionísio TJ, Louzada JC de A, Viscelli BA, Dionísio EJ, Martuscelli AM, Boaqueiro JR, Santos CF, Amaral SL. Dexamethasone negative side effects on insulin signaling is prevented by exercise training: role of IRS-1 and p-AKT. FASEB Journal. 2010 ; 24[citado 2024 nov. 14 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation